Crescita Therapeutics Inc.
CRRTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $6 | $4 | $7 |
| % Growth | -13.5% | 76.2% | -48.8% | – |
| Cost of Goods Sold | $3 | $2 | $2 | $4 |
| Gross Profit | $3 | $4 | $2 | $3 |
| % Margin | 52.9% | 61.4% | 49.4% | 43.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $3 | $0 | $0 |
| SG&A Expenses | $2 | $3 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $3 | $3 |
| Operating Income | -$0 | $1 | -$1 | -$0 |
| % Margin | -3% | 9.4% | -30% | -3.9% |
| Other Income/Exp. Net | $1 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | $1 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $1 | $1 | -$1 | -$0 |
| % Margin | 14% | 12.8% | -26.4% | -2.3% |
| EPS | 0.04 | 0.042 | -0.049 | -0.008 |
| % Growth | -5% | 185.9% | -483.3% | – |
| EPS Diluted | 0.04 | 0.04 | -0.05 | -0.008 |
| Weighted Avg Shares Out | 19 | 19 | 19 | 19 |
| Weighted Avg Shares Out Dil | 19 | 19 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | -$1 | $0 |
| % Margin | 21.3% | 18.7% | -16% | 3% |